...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Tensha Therapeutics sold to Roche
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I think this bodes well for Zenith. The big boys will want to have similar horses in their stable to be able to compete in this race. Zenith may be the Secretariat of this field.

IMO.

masila

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply